Blodi, B., A. Domalpally, E. Corkery, A. Osborne, S. Blotner, S. Grzeschik, and S. Gune. Prevalence of Macular Atrophy in the MARINA Study of Ranibizumab Versus Sham for Neovascular Age-Related Macular Degeneration. Ophthalmol Retina, 2023, p. Epub PubMed Text.
Abstract
Objective: Determine prevalence, progression rates, and associations of newly detectable macular atrophy (MA) in patients with choroidal neovascularization (CNV) secondary to neovascular age-related macular degeneration (nAMD) with/without ranibizumab treatment.
Keywords: Macular atrophy; Neovascular age-related macular degeneration; Ranibizumab.